Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Mitochondrial DNA as a biomarker for acute central serous chorioretinopathy: A case-control study

Hashida, Noriyasu, Asao, Kazunobu, Hara, Chikako, Quantock, Andrew J. ORCID:, Saita, Ryotaro, Kurakami, Hiroyuki, Maruyama, Kazuichi and Nishida, Kohji 2022. Mitochondrial DNA as a biomarker for acute central serous chorioretinopathy: A case-control study. Frontiers in Medicine 9 , 938600. 10.3389/fmed.2022.938600

[thumbnail of fmed-09-938600.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (1MB)


The literature suggests that stress may play a pivotal role in the precipitation of acute central serous chorioretinopathy (CSC) because chorioretinal integrity can be affected by the psychosocial state of the patient, indicating the need for a biomarker. Not only physical stress but also psychological stress causes many types of physical disorders. However, little is known about the pathophysiology of stress-induced disease. The objective of this study was to investigate whether serum factors might be involved in the development of stress-induced ocular diseases. Methods: This observational case series included 33 eyes of 33 consecutive patients with treatment-naïve acute CSC. Fifty eyes of 50 age-matched healthy volunteers were included in this study as non-CSC controls. Serum samples were collected from all participants, and the levels of mitochondrial DNA (mtDNA) were measured by quantitative real-time (RT)-PCR. Serum levels of high-mobility group box (HMGB) 1 and 8-hydroxy-2′-deoxyguanosine (8-OHdG), biological markers of acute/chronic inflammation and oxidative stress, were also measured. The relationships between serum mtDNA, 8-OHdG, and HMGB1 concentrations were investigated by multivariate regression analysis, alongside an assessment of clinical data. Results: In the treatment-naïve acute CSC group, the serum mtDNA levels (36.5 ± 32.4 ng/mL) were significantly higher than the levels in the control group (7.4 ± 5.9 ng/mL; p < 0.001). Serum levels of 8-OHdG and HMGB1 in treatment-naïve acute CSC patients measured 0.12 ± 0.08 ng/mL and 18.1 ± 35.0 ng/mL, respectively, indicating that HMGB1 levels were elevated in CSC compared with the control group. Multivariable regression analysis demonstrated that increased serum mtDNA levels were significantly associated with the height of serous retinal detachment. Conclusion: We showed serum mtDNA and HMGB1 level elevation and its relation to the clinical activities of CSC, indicating that serum mtDNA and HMGB1 could serve as biomarkers for the acute phase of the disease. The use of these biomarkers makes it possible to predict disease onset and determine disease severity.

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Optometry and Vision Sciences
Additional Information: License information from Publisher: LICENSE 1: URL:
Publisher: Frontiers Media
Date of First Compliant Deposit: 6 July 2022
Date of Acceptance: 6 June 2022
Last Modified: 10 May 2023 08:51

Citation Data

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics